Our partners at Diabetes Canada have just announced their 2021 research competition. Learn more below.

Diabetes Canada’s 2021 research competition is now open for applicants! This year, Diabetes Canada will be awarding 15 End Diabetes:100 Awards. Each of the 15 awards commits a $100,000 operating grant annually for three years to support brilliant scientists and provide them with the freedom, autonomy, and resources to set them on the road to breakthrough discoveries.

The objective of the End Diabetes:100 Awards are:

• To support researchers in the discovery of the biomedical, clinical, health services and/or population health factors that lead to the onset and progression of all types of diabetes and related complications.
• To develop solutions aimed at the prevention, management, or cure for people living with diabetes.

There is a two-stage application and review process:

1. Applicants are invited to submit a letter of intent (LOI).
2. After panel review, selected applicants will be invited to submit a full application. Diabetes Canada intends to advance the top ranking LOIs to the application stage to ensure a funding success rate of 50%.

At this stage, we invite all interested applicants to complete and submit by email an LOI using Diabetes Canada’s letter of intent submission template. Please note all LOIs are due by June 20, 2021, 7:59 p.m. ET.

Please check the Diabetes Canada website and review the 2021 Research Competition Guide for full details on the award being offered and eligibility criteria, policies, and timelines for the 2021 competition: https://www.diabetes.ca/research/grants—awards/competition

We thank you for your interest in the Diabetes Canada research competition, and for the crucial role you play in the advancement of diabetes research. Diabetes Canada is committed to working together with talented researchers towards our common goal of creating a world free of the effects of diabetes.